[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 2.48% 82.60 81.40 82.60 82.60 80.40 80.40 163,853 16:35:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 65.3 15.4 2.5 33.7 383

Ekf Diagnostics Share Discussion Threads

Showing 3751 to 3775 of 3950 messages
Chat Pages: 158  157  156  155  154  153  152  151  150  149  148  147  Older
DateSubjectAuthorDiscuss
30/8/2021
06:45
Thanks James (you beat me to it!), I have been following Luke on Linkedin - The New Beginning. After careful thought and consideration, I am honoured to officially announce that I have accepted the prestigious position of Chief Scientific Officer at EKF Diagnostics. I am grateful to Mike Salter and the EKF Family who have supported me this past year. I have a lot to prove and even more to offer, and I can’t wait to get started! hTTps://www.linkedin.com/posts/luke-daum-01661_ekf-cso-teamwork-activity-6837913219458224128-fK-h
wan
30/8/2021
06:39
Luke Daum of Longhorn Vaccines & Diagnostics (the driving force behind the PrimeStore MTM and ATM collection devices) has recently tweeted that he has accepted the post of Chief Scientific Officer at EKF. Not clear of this is full time or whether he will combine it with his similar role at Longhorn, but no doubt we will hear more shortly from EKF. I think that it is a very positive development. It also underlines he importance of EKF’s US operations. I wonder if the company will look at a dual listing at some point.
james188
28/8/2021
10:44
Many thanks wan
pldazzle
28/8/2021
10:08
pldazzle, apologies for the delayed reply regarding SBI while I gathered my thoughts etc. I don't share your intrigue in the parallels between SBI and EKF. EKF is a reliable and respected global manufacturer and contract manufacturer of point of care products (soon to include home diagnostics), central laboratory products, and specialised life science products, serving and supplying important operators such as SBI, and indeed much larger global players too e.g. Roche, ThermoFisher to name but two (not to mention an even larger private sector partner!). With key relationships/partnerships playing an important and determining element in the degree of success for the related parties. Both companies are in parallel though in terms of being in growth mode and cash generative, which includes but is 'not limited' to Covid-19 testing, but at different ends of the testing spectrum. Put another way, SBI is closer to the patient. Julian Baines recently described EKF as supplying the picks and shovels to the Covid testing opportunity, I think that that analogy will be even more applicable but in a much wider context in terms of the global opportunity created by the pandemic in elevating healthcare and diagnostics to a different level! So, both companies are operating in a 'similar' space in terms of addressing healthcare and diagnostics markets, at a very important time, and a time span that is likely to represent a long-term multi-year opportunity, which in turn puts them both in play regarding merger and acquisitions, with both companies also indicating an interest in complementary, earnings-enhancing acquisitions with key strategic value. Arguably, both could be diners as well as being on the menu. However, I don't think we need worry too much about EKF being bought out anytime soon, well I certainly hope not as I am very confident about EKF delivering on their growth strategy. And I am further encouraged by the new era of Mike Salter becoming CEO, who has been both instrumental and an excellent cultivator of EKF growth already, and I am confident there is far more potential yet to be realised. This new EKF era in turn enables the current CEO to focus on delivering further value from the Company’s relationship with Mount Sinai Innovation Partners. With excellent growth and value creation prospects, a progressive dividend policy to boot, and subsequently EKF shares in demand, what's not to like!
wan
28/8/2021
10:05
Thanks pldazzle. It highlights another important user (among many) and indeed the key rationale and attributes of using PrimeStore MTM, so I hope you don't mind me cut and pasting it below (for ease of navigation) - 4.40 Introduction of PrimeStore Transport Medium In order to alleviate some of the pressures placed on service delivery and to improve the turnaround time for COVID-19 results, the Virology department implemented the use of PrimeStore (Longhorn Vaccines and Diagnostics, USA) molecular transport medium in December 2020 for the collection of COVID-19 test samples within the Trust. This new medium contains chemicals which have been demonstrated by PHE to inactive SARS- CoV2, rendering it non-infectious within 10 minutes. MFT was the first Trust in the UK to implement this novel transport medium, significantly reducing the time taken for samples to be tested in the laboratory by eliminating the ‘make safe’ step required to inactivate samples prior to testing. Since the introduction of the new transport medium for all patient testing within the Trust, the compliance with the 24-hour turnaround time for testing has significantly increased for both ORC and Wythenshawe sites (chart 4)
wan
28/8/2021
10:05
Its p316 of 424 albeit its labelled p25 for no apparenet reason.
shanklin
28/8/2021
09:21
Some months old, but nonetheless interesting See para 4.40 on page 25 hTTps://mft.nhs.uk/app/uploads/2020/11/MFT-Website-BoD-public-12.07.21-combined-v2.pdf
pldazzle
28/8/2021
05:42
Wan, thanks for the Lloyds Pharmacy link and their using MHC tests, your recollection is confirmed (that they have a primestore contract) by opening the "what's included" when you purchase the kit: What's included 1x Sterile CE marked flocked swab 1 x 5.0ml tube containing 1.5ml of PrimeStore MTM inactivation media within a labelled biohazard ShuttlePouch containing an absorbent pad 1 x Instructions for use 1 x Essential checklist card 1 x Return postage bag 1 x Royal Mail tracked 24 postage label
travestor
27/8/2021
15:45
EKF GOING UP https://www.youtube.com/watch?v=gTCUuTGNEnI
sirshagalot
27/8/2021
15:30
Good to see the share price consolidating at 80p and above. About ready for a push upwards before the results on 14th September methinks.
rivaldo
27/8/2021
14:11
Not at all Mr Tongster, not at all. I've got a bit longer time horizon than you. Still waiting for you to claim to be in this before it goes up. You must have lost a lot of money trading this to be still around despite so many other easier trades
mg1982
27/8/2021
13:05
Our clueless friend Mg must be really praying for a breakout isn't he. Been a long wait for him innit
tongosti
27/8/2021
09:08
I have no idea what market share PrimeStore has, but given the attributes, in certain applications it would attain a high market share. Question (b) and (c) will need to be addressed by EKF, as I don't know the specific answer. However, in a sort of answer to question (b) what I do know from a question that I previously asked, was that EKF are the only manufacturer and supplier of the most important, patented and closely guarded ingredients for PrimeStore MTM. And if still correct, this could matter even more now that the benefits and attributes of the patent protected PrimeStore MTM have been realised and widely recognised globally. And if other players get permission from Longhorn to launch similar versions/replication of PrimeStore MTM, then the volumes of closely guarded ingredients produced by EKF could materially increase. In another sort of answer to (c), PBS is not a Longhorn/PrimeStore related product, and for which I think turnover will prove to be very high as it is being used in various collection kits in the US, UK and Europe. PBS solution was introduced into the market Q4 2020, and due to an increase in demand, additional production lines for Phosphate Buffered Saline (PBS) were established Q1 2021 at Boerne, South Bend, Barleben and Cardiff sites. It's also worth considering that PBS (and MTM & ATM) has application for testing 'beyond' Covid collection kits.
wan
27/8/2021
08:19
Many thanks wan, that's helpful. For transport media/sample collections products, would you know (a) what market share PrimeStore has, (b) roughly what percentage of PrimeStore's transport media EKF manufactures i.e. how much are EKF's competitors responsible for, (c) what percentage of EKF's transport media turnover (if any) is non-PrimeStore related? And: Any thoughts on SBI?
pldazzle
27/8/2021
07:28
pldazzle...PBS and MTM (and ATM) are sample transport mediums/sample collection products contained in a collection tube into which a sample swab is inserted, they are not tests in themselves and are thus transported to labs for testing. Thus they are included within test 'collection' kits for lab PCR testing, including use in test to travel and tests to release kits, including via sample collection/drive-through etc. I am not an expert, but fwiw here is a short explanation of my understanding - PBS is Phosphate Buffered Saline used for sample collection, ultimately used for PCR lab testing. Phosphate Buffered Saline offers advantages over say PrimeStore MTM in terms of supply chain logistics and ease of use due to the absence of potentially hazardous preservative fluid. Thus, PBS is used for direct-to-consumer 'self-collect' kits as it is a non-toxic solution. Swabs in PBS can be transported and stored at between -20°C and +40°C for up to 120 hours (5 days) thus in certain circumstances cold chain storage and transportation is required prior to lab testing. PrimeStore MTM is an inactivation transport medium also for PCR lab testing, and is better utilised when the sample is not self-collected, or in a situation where infection control is perhaps more difficult or absent, and/or where cold chain logistics is not available, and where it may be difficult for the labs to achieve the appropriate or required Biosafety Level. hTTps://lhnvd.com/primestore-mtm PrimeStore ATM is a new product optimised for molecular testing (such as PCR) that is not yet commercially available and is currently for research use only, so details are still limited. PrimeStore ATM is a sample collection device that also inactivates viruses, but importantly it does not contain the ingredients that would classify it as toxic, it also enables an extraction-free process which is usually required for molecular tests such as PCR. Apparently, ATM can also enable highly sensitive antigen testing capabilities, which in my book means that it may have important utility in 'enabling' rapid testing such as point-of-care testing. Time will tell. hTTps://lhnvd.com/primestore-atm Molecular Transport Media hTTps://www.ekfdiagnostics.com/molecular-transport-media.html
wan
27/8/2021
05:02
Boadicea...I already own Trellus shares in my ISA (Ordinary Shares). So, I think that that note is because currently they are A shares (the dividend or entitlement shares held in trust), but the A shares will automatically convert into ordinary shares in Trellus on the basis of one Ordinary Share for each A Share on admission to trading on AIM, so I cannot see any reason either why they will not be eligible.
wan
26/8/2021
22:36
wan - I'm intrigued by what appear to be parallels between EKF and SourceBio (SBI). Both are in the Chris Mills stable; both have a major involvement, directly or indirectly, in COVID testing; and SBI is known to be a (past or present) customer of EKF, although I'm not sure on what scale. Both are also cash rich. I'd be interested in your thoughts on whether some kind of closer alignment, perhaps even a merger, might make sense. In passing, I'm also getting rather confused about the different varieties of COVID tests and their respective pros and cons. I'm aware that certain tests are for whether you are infected, others for whether you are immune, but that's about as far as it goes. You've mentioned e.g. PBS, MTM and ATM, but as a layman I confess that I understand neither how they differ, nor the extent of EKF's competition for any of them - or more accurately, I suppose, for test kits involving any of them. Perhaps others feel the same. Is there an idiot's guide somewhere?
pldazzle
26/8/2021
21:35
wan - Another platforms show the lock-up TRLS shares in the ISA portfolio annotated as "Lock-up period interim line". I suppose this does not necessarily prove they will be admitted when released although being 'payment' of a deferred dividend I see no reason why not.
boadicea
26/8/2021
21:34
wan - Another platforms show the lock-up TRLS shares in the ISA portfolio annotated as "Lock-up period interim line". I suppose this does not necessarily prove they will be admitted when released although being 'payment' of a deferred dividend I see no reason why not.
boadicea
26/8/2021
15:26
Tic toc tic toc
tongosti
26/8/2021
13:25
Testing 80p again !
wanttowin
26/8/2021
11:55
Relevant post from the Trellus Health thread - Update...in answer to my complaint to Barclays Smart Investor, part of which was them not showing the Trellus Health 'Entitlements', they have written to me stating they are currently in the process of setting up a line of stock called Trellus Entitlements to enable them to show these new shares. Smart Investor now shows such entitlements in your ISA as "This product is no longer eligible in ISA" but provides a link into Corporate Actions, where they are shown, including all of the relevant details etc. with the same situation in the SIPP's. So, let's also hope that the same will apply to the next value enhancement from EKF's relationship with Mount Sinai Innovation Partners.
wan
26/8/2021
10:52
Kudos to 1xtrader over on the MyHealthChecked thread for highlighting that Lloyds Pharmacy is now also selling the MyHealthChecked Covid-19 sample collection kit - hTTps://lloydspharmacy.com/products/myhealthchecked-covid-19-sample-collection-kit-pcr-test?variant=39389445390399 Recall that MyHealthChecked Plc (AIM: MHC), signed a Manufacturing Agreement with EKF Diagnostic Holdings plc ("EKF") for PrimeStore® MTM sample collection devices.
wan
26/8/2021
10:14
If EKF upgrade Quo-Test so that the FDA clearance includes screening and diagnosis, along with use at point of care e.g. in the doctors office, then that will, in my humble opinion, have a very positive impact on EKF's diabetes revenues. What is also worthy of note, is the indication that Quo-Test is being upgraded to also account for markets outside of the US - Diabetes is rising worldwide... and is set to rise even further In 2000, the global estimate of adults living with diabetes was 151 million. By 2009 it had grown by 88% to 285 million. Today, we calculate that 9.3% of adults aged 20–79 years – a staggering 463 million people – are living with diabetes. A further 1.1 million children and adolescents under the age of 20, live with type 1 diabetes. A decade ago, in 2010, the global projection for diabetes in 2025 was 438 million. With over five years still to go, that prediction has already been surpassed by 25 million. IDF estimates that there will be 578 million adults with diabetes by 2030, and 700 million by 2045. hTTps://www.diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.htm I would not goes a far to say that I would drink to that given the complications and consequences of diabetes, but I would raise a glass (of wine!) to EKF for playing their part in addressing and preventing complications and for promoting and aiding healthier outcomes!
wan
26/8/2021
09:50
Fresh wine in old bottle - get in there fella!
tongosti
Chat Pages: 158  157  156  155  154  153  152  151  150  149  148  147  Older
ADVFN Advertorial
Your Recent History
LSE
EKF
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211028 03:23:55